References
- Ayça B, Akin F, Çelik Ö, Yüksel Y, Öztürk D, Tekiner F, Çetin Ş, Okuyan E, Dinçkal MH. Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention. Platelets 2015;26(7):638–644.
- Ayça B, Akin F, Okuyan E. Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention. Platelets 2015;26(8):816.
- Sertoglu E, Uyanik M. Value of combination of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in primary percutaneous coronary intervention. Platelets 2015;26(8):814–815.
- Smith RA, Bosonnet L, Ghaneh P, Sutton R, Evans J, Healey P, Garvey C, Hughes M, Raraty M, Campbell F, Neoptolemos JP. The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer. Surgery 2008;143:658–666.
- Koh CH, Bhoo-Pathy N, Ng KL, Jabir RS, Tan GH, See MH, Jamaris S, Taib NA. Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer 2015;113:150–158.
- Kim EY, Lee JW, Yoo HM, Park CH, Song KY. The platelet-to-lymphocyte ratio versus neutrophil-to-lymphocyte ratio: Which is better as a prognostic factor in gastric cancer? Ann Surg Oncol 2015;22(13):4363–4370.
- Peng W, Li C, Zhu WJ, Wen TF, Yan LN, Li B, Wang WT, Yang JY. Prognostic value of the platelet to lymphocyte ratio change in liver cancer. J Surg Res 2015;194:464–470.